Patents by Inventor Simon Sebastian Brack

Simon Sebastian Brack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL NUCLEIC ACID MOLECULES WITH ANTITUMORAL ACTIVITY
    Publication number: 20170281768
    Abstract: The present invention relates to a binding molecule that specifically binds to two different epitopes of an antigen expressed on tumor cells, wherein the binding molecule comprises: (a) a first binding (poly)peptide that specifically binds to a first epitope of said antigen expressed on tumor cells, wherein said first binding (poly)peptide is a Fyn SH3-derived polypeptide; and (b) a second binding (poly)peptide that specifically binds to a second epitope of said antigen expressed on tumor cells. The present invention further relates to a nucleic acid molecule encoding the binding molecule of the invention, a vector comprising said nucleic acid molecule as well as a host cell or a non-human host transformed with said vector. The invention further relates to a method of producing a binding molecule of the invention as well as to pharmaceutical and diagnostic composition.
    Type: Application
    Filed: March 9, 2017
    Publication date: October 5, 2017
    Inventors: Simon Sebastian BRACK, Frédéric MOURLANE, Isabella TOLLER, Richard WOODS, Julian BERTSCHINGER, Dragan GRABULOVSKI, Babette SCHADE, Kristina KLUPSCH, Helen HACHEMI
  • IL-17 Binding Compounds and Medical Uses Thereof
    Publication number: 20160368957
    Abstract: The present invention relates to new IL-17 inhibiting polypeptides, corresponding fusion proteins, compositions and medical uses thereof.
    Type: Application
    Filed: May 17, 2016
    Publication date: December 22, 2016
    Inventors: Dragan GRABULOVSKI, Michela Silacci Melkko, Frederic Mourlane, Simon Sebastian Brack, Julian Bertschinger, Nadia Beaenziger, Sarah Batey
  • IL-17 binding compounds and medical uses thereof
    Patent number: 9376477
    Abstract: The present invention relates to new IL-17 inhibiting polypeptides, corresponding fusion proteins, compositions and medical uses thereof.
    Type: Grant
    Filed: August 24, 2010
    Date of Patent: June 28, 2016
    Assignee: Covagen AG
    Inventors: Dragan Grabulovski, Michela Silacci Melkko, Frédéric Mourlane, Simon Sebastian Brack, Julian Bertschinger, Nadja Baenziger, Sarah Batey